Patient, Consumer Groups Press For More Oversight Of Device Iterations
This article was originally published in The Gray Sheet
Executive Summary
Patient and consumer groups urged better FDA control over modifications to marketed products and expressed support for agency oversight of laboratory-developed tests at a recent update meeting on device user fee reauthorization.